HeartBeam (NASDAQ: BEAT) reported first-quarter 2026 operational and financial results highlighted by the launch of its initial commercial partnerships in key U.S. markets, progress in its heart ...
The study will enrol around 50 high-risk coronary artery disease patients whose resting ECGs show no signs of ischemia.
HeartBeam (NASDAQ: BEAT) announced the initiation of a pilot study evaluating its investigational on-demand 12-lead ECG ...
Please provide your email address to receive an email when new articles are posted on . An AI-based ECG model more accurately diagnosed a type of heart attack compared with standard of care. The ...
An investigation has found a "concerning level of variation" in how 12-lead electrocardiogram (ECG) skills are taught in UK undergraduate paramedic programmes. A report by the Health Services Safety ...
Austin, Texas, May 14th, 2026, FinanceWireHeartBeam (NASDAQ: BEAT) reported first-quarter 2026 operational and financial ...